ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2022 and provided an update on progress toward achieving key corporate objectives, as well as commercial, clinical and pipeline development milestones. “Exelixis had a strong start to 2022 as we continued to gain momentum across all components of our business,” said Michael M. Morrissey, Ph.D., President and Chief Executive Officer, Exelixis. “We are pleased with the growth
Full ArticleExelixis Announces First Quarter 2022 Financial Results and Provides Corporate Update
Business Wire
0 shares
1 views